Privia Health Group, Inc. PRVA
NASDAQ · Vereinigte Staaten · Finanzen
$20,25+0,56 (+2,84 %)
Markt geöffnet· · USD · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Markt geöffnet· · USD · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Gesamtrendite inklusive Dividenden.
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Activists recently filed disclosures with the SEC that included Privia Health Group (PRVA), putting fresh attention on the physician-enablement specialist and how its shares trade around the latest ownership updates. At around US$19.85 per share, Privia Health Group has been under pressure, with the share price falling 6.4% over the past month and 16.1% over the last quarter. The 1-year total shareholder return is down 11.3%, pointing to fading momentum that may reflect investors reassessing...
Wo der Kurs im Verhältnis zu seinen 50- und 200-Tage-Durchschnitten steht.
Makkler Fair Value, Finanzgesundheit, Analystenmeinung, Vergleichsunternehmen und MakklerAI.
Privia Health Group shares most recently closed at US$19.85, and the weaker run in the stock raises a straightforward question for investors who care about valuation. Is the current price fully supported by the earnings profile of Privia Health Group, or has sentiment moved further than the underlying profit story? Over the past 5 years the share price has fallen 23.1%, which puts the focus firmly on whether the current earnings justify staying invested or stepping in now. The business model...
Aktuelle Schlagzeilen Dritter zu diesem Unternehmen, getrennt von Makklers eigener Redaktion und mit Verlinkung zum Herausgeber. Für die Richtigkeit ist der jeweilige Herausgeber verantwortlich.